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A B S T R A C T
Stem cells can diﬀerentiate into various body tissues and organs and thus are considered as promising tools for
cell therapy and tissue engineering. Early passage stem cells have high diﬀerentiation ability compared to late
passage stem cells. Thus, it is important to use early passage stem cells in cell therapy. Here, we investigated
whether cell migration could be used to compare young and senescent cells. We used ‘electrotaxis’ where cells
under electric treatment move towards the anode or cathode. Without an electric stimulus, stem cells moved
randomly. However, under a direct electric current, the cells moved with directionality. Under stimulation with
a direct electric current, early passage stem cells moved towards the anode; when the cells became senescent
with increasing passages, the percentage of cells migrating to the anode decreased. These results suggest that the
behavior of stem cells under the inﬂuence of a direct electric current is also related to their passage number.
Therefore, electrotaxis migration analysis can be used to distinguish between young cell and senescent cells.
1. Introduction
Cell therapy has been widely examined and is used to treat various
disease. Stem cells are promising sources for tissue engineering and cell
therapy (Thomson et al., 1998). Particularly, mesenchymal stem cells
(MSCs) have been explored as attractive therapeutic agents because of
their capacity to proliferate and diﬀerentiate into multiple cell lineages
such as osteocytes, adipocytes, and chondrocytes (Borougeni et al.,
2012). MSCs are a class of multipotent stem cells that can be isolated
from various tissues including adipose tissue, bone marrow, and per-
ipheral blood. However, stem cells are associated with safety issue such
as tumorigenicity (Ding et al., 2015). Previous studies showed that
when undiﬀerentiated stem cells are implanted, they can form a ter-
atoma (Brivanlou et al., 2003; Prokhorova et al., 2009; Ben-David and
Benvensity, 2011; Hentze et al., 2009; Barkholt et al., 2013; Nussbaum
et al., 2007; Dazzi and Horwood, 2007). Therefore, to enhance the ef-
fects of stem cells in cell therapy, it is important to identify appropriate
cell sources. It is well-known that cell diﬀerentiation and function de-
cline with passage number and thus early passage stem cells should be
used in cell-based therapies.
The proliferation rates and other properties of cells gradually
change with increasing passage numbers (Gu et al., 2016). In vitro, stem
cells undergo senescence as the passage number increases and also lose
their innate characteristics (Kuilman et al., 2010). Senescent cells have
altered morphology, produce senescence-associated heterochromatin
foci, show decreased proliferation and diﬀerentiation abilities, exhibit
senescence-associated ß-galactosidase activity, and have altered activ-
ities of cell cycle inhibitors such as p16, p15, p21 and p53 (Kuilman
et al., 2010; Chen et al., 2015; Simonsen et al., 2002). Stem cells also
show a decreased ability to diﬀerentiate during senescence (Choudhery
et al., 2014; Roobrouck et al., 2008; Fehrer and Lepperdinger, 2005).
These changes may inﬂuence stem cell therapy.
Application of a direct electric current can induce the directional
migration of many cell types, including mesenchymal stem cells, ﬁ-
broblasts and endothelial cells. This phenomenon is known as ‘elec-
trotaxis’ (Iwasa et al., 2017). During electrotaxis, cells move towards
the anode or cathode under a direct electric current. Exogenous electric
stimulation can be a cue that controls cell behavior. Electrotaxis is a
simple method for controlling cell migration. However, the migration
direction and rate can be inﬂuenced by external stimulation and innate
cellular features (Kim et al., 2017).
In this study, we investigated the eﬀect of stem cell passage number
on directional migration and evaluated passage-related reactions oc-
curring in response to electric stimulus. Additionally, we examined
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senescent properties about the cells we used in this study.
2. Materials and methods
2.1. Cell cultures
Human mesenchymal stem cells (hMSCs, Lonza, Basel, Switzerland)
were cultured in MSC growth medium (Lonza). Adipose-derived MSCs
(ADSC, Lonza) were cultured in adipose-derived stem cell growth
medium (Lonza). Tonsil-derived mesenchymal stem cells (TMSC, pro-
vided by Dr. Jo in Ewha Woman's University (Seoul, Korea)) were
cultured in Dulbecco's Modiﬁed Eagle's Medium (Welgene, Seoul,
Korea) containing 10% fetal bovine serum and 1% antibiotics
(Welgene). Cells were incubated at 37 °C in a 5% CO2 atmosphere in a
humidiﬁed incubator. Fresh complete medium replacement was con-
ducted every 3–4 days. When the cells reached 90% conﬂuence in the
ﬂask, adherent cells were detached using 0.25% trypsin EDTA
(Welgene) and then passaged. In this study, we selected passages 5, 10,
and passage 15 as representative of early, middle, and late passage
cells.
2.2. Senescence associated ß -galactosidase staining & activity
Senescence-associated ß-galactosidase staining was performed using
a Cellular Senescence Detection kit (Cell Biolabs, San Diego, CA, USA)
according to the manufacturer's protocol. Brieﬂy, passage 5, 10, and 15
TMSCs, hMSCs, and ADSCs were cultured at a density of 1×105 per
well in 12-well plates and incubated overnight. The cells were washed
with Dulbecco's phosphate-buﬀered saline (DPBS) and ﬁxed with 4%
paraformaldehyde for 10min. After washing the cells with DPBS, they
were stained with cell staining working solution for 24 h in an in-
cubator at 37 °C in the dark. Senescent cells were observed under a
bright-ﬁeld microscope (Olympus CKX41, Tokyo, Japan).
Senescence associated ß-galactosidase activity was evaluated using
the cellular senescence assay kit from Cell Biolabs according to the
manufacturer's protocol. Passage 5, 10, and 15 TMSCs, hMSCs, ADSCs
were seeded at a density of 5×104 per well in 48-well plates and in-
cubated overnight. After washing the cells with cold DPBS, the cells
were lysed with lysis buﬀer for 10min at 4 °C. Whole cell lysates were
centrifuged for 10min at 4 °C in 14,000 rpm. The supernatants were
transferred into black 96-well plates combined with an equal amount of
reaction buﬀer, and incubated at 37 °C with protection from light for
3 h. The reaction mixtures were neutralized by adding stop solution and
the activity of senescence-associated ß –galactosidase was measured
with a ﬂuorescence plate reader (Flexstation3, Molecular Devices,
Sunnyvale, CA, USA) at excitation and emission wavelengths of 360 and
465 nm, respectively. The data were expressed as the mean relative
ﬂuorescence reading normalized to the total protein concentration.
2.3. MTT assay for cell proliferation
The cell proliferation of TMSCs, hMSCs, and ADSCs was assessed by
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2-H-tetrazolium bromide
(MTT) assay at passages 5, 10, and 15. Cells were seeded into 48-well
plates at a density of 1000 cells per well. After 1, 2, 3, 4, 5, 6, and
7 days, the cells were washed with DPBS, MTT was added to each well,
and the cells were incubated for 3 h at 37 °C in the dark. MTT solution
was aspirated from the cells and a mixture of dimethyl sulfoxide and
glycine buﬀer was added. After purple formazan crystals were fully
dissolved, they were transferred to a 96-well plate. The absorbance
values of the samples were read on a microplate reader at a wavelength
of 570 nm (Molecular Devices).
2.4. Western blot analysis
Cells were lysed in RIPA buﬀer supplemented with 1mM PMSF.
Proteins were separated by 15% sodium dodecyl sulfate-polyacrylamide
gel electrophoresis and transferred onto polyvinylidene diﬂuoride
membranes. The primary antibodies recognized the following proteins:
p16, p21, proliferating cell nuclear antigen (PCNA) and β-actin (Cell
Signaling Technology, Danvers, MA, USA). After incubation with
horseradish peroxidase-linked anti-rabbit or anti-mouse IgG secondary
antibody (Cell Signaling Technology), protein expression was evaluated
with SignalFire ECL reagent (Cell Signaling Technology).
2.5. Application of electrotaxis stimulation to stem cells
To directly apply electric stimulation to the stem cells, a customized
agar-salt electrotaxis chamber with an incubator system was used. This
equipment consisted of an electrotaxis incubator connected to a mi-
croscope to observe live cells and a chamber system for applying the
direct electric current to the cells (Kim et al., 2017). Electrotaxis ana-
lysis was performed in the incubator system (CCP ver 3.8, Live Cell
Instrument, Seoul, Korea) equipped with an inverted microscope
(Olympus). The stem cells were seeded at a density of 4× 103 cells on a
slide glass with a silicon O-ring with an inner diameter of 16mm and
incubated overnight in a CO2 incubator. To place the cells in the elec-
trotaxis incubator, the silicon O-ring was removed and the cell-seeded
slide glass was placed in the bottom chamber and upper chamber. A
silicon gasket was placed on the top of the slide glass. For electric
current application, agar-salt bridges were used to connect the elec-
trodes at each sides of the chamber. The DC pulse power supply (Daedo
Powertronics Co. Ltd., Seoul, Korea) supplied the electric current to the
chamber through the 2% agar salt bridge immersed in Steinberg's so-
lution. During electric stimulation, the current was monitored with a
digital power meter (Fluke, Everett, WA, USA) to ensure a constant
electric current. Cell images were captured every 5min using a charge-
coupled device camera attached to an inverted microscope. An electric
current of 1000 μA was applied for 3 h (Kim et al., 2017).
2.6. Analysis of cell migration
Cells were visualized with a microscope using a 10× objective lens.
The cell migration speed was calculated by manual tracking and che-
motaxis tool plugin (v.1.01, distributed by ibidi GmbH, Munchen
Germany) in the ImageJ program (ImageJ 1.37v, National Institutes of
Health, Bethesda, MD, USA). Without an electric current, 40 stem cells
were tracked at passages 5, 10, and 15. Under an electric current at
1000 μA for 3 h, 80 stem cells were tracked at passages 5, 10 and 15.
Cell migration was divided into the anode (direction of electric current,
right side) and cathode (opposite direction of electric current, left side)
reaction by using the chemotaxis tool plugin.
2.7. Statistical analysis
Statistical analyses were performed with SPSS 23.0 software (SPSS,
Inc., Chicago, IL, USA). Comparison within the studied groups was
performed by paired t-test, while diﬀerent groups were evaluated by
analysis of variance. A value of p < .05 is considered to indicate sta-
tistical signiﬁcance.
3. Results & discussion
3.1. Comparison of senescence properties in early, middle, and late passages
Various methods can be used to monitor MSC senescence. One of the
most convenient indicators is the number of cell passages. However, the
passage number can be aﬀected by various factors, such as the seeding
density and the length of incubation. Therefore, senescence properties
are need to be investigated. Staining of senescent cells based on accu-
mulation of SA-β-gal is a widely used approach. Senescent cells show
common biochemical markers such as SA-ß-gal activity. When stem
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cells become senescent during serial passaging, the numbers of SA-ß-
gal-positive cells increase (Wagner et al., 2008). We conﬁrmed the
diﬀerent abilities of cell growth for stem cells passaged for diﬀerent
amounts of time. Innate factors in the cell change during long-term
culture, resulting in diﬀerence in proliferation ability (Kippin et al.,
2005; Amit et al., 2000) Additionally, evaluation of senescence-speciﬁc
gene expression markers can be used to identify senescent cells. In this
study, TMSCs, hMSCs, and ADSCs were serially passaged 5 to 15 times,
and these cells were used to conﬁrm senescence by SA-β-gal, pro-
liferation ability, and senescent gene expression. In many studies, stem
cells passaged more than 10 times are deﬁned as senescent (Izadpanah
et al., 2008; Rilianawati et al., 2018; Osipova et al., 2011; Zhuang et al.,
Fig. 1. Senescence characteristic of stem cells during serial passaging.
(A) Senescence-associated ß-galactosidase staining for TMSCs, hMSCs, and ADSCs at passages 5, 10, and 15. Red arrow indicates senescence-associated ß-ga-
lactosidase-positive stained cells. Scale bar= 100 μm. (B) Senescence-associated ß-galactosidase activation measured by ﬂuorometric analysis of TMSCs, hMSCs, and
ADSCs at passages 5, 10, and 15. * p < .05. (C) Cell proliferation analysis of TMSCs, hMSCs, and ADSCs by MTT. TMSCs, hMSCs, and ADSCs -at passages 5, 10, and
15 were evaluated from 1 day after seeding to 7 days after seeding. Formazan crystal formation was measured at 570 nm. (D)Western blot analysis to detect
senescence markers p16 and, p21 and proliferation marker PCNA. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web
version of this article.)
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2015).
In SA-β-gal staining using ﬂuorometric substrate, we detected
strong positive staining of β-galactosidase with increasing passage of all
stem cells (Fig. 1A). SA-ß-gal activity was normalized by the total
protein concentration to obtain quantitative results for each passages.
In TMSCs, middle passage cells showed similar activities compared to
early passage cells, but late passage cells showed 200% higher activity.
Similar tendencies were observed for ADSCs. Late passage ADSCs had
130% higher activity than early passage. In hMSCs, middle and late
passage cells showed 130% higher activity than early passage cells
(Fig. 1B). As a result, late passage cells showed high SA-ß-gal activity
compared to early passage cells in all cell types, indicating the higher
ages of late compared to early passage cells.
The proliferation rates of TMSCs, hMSCs and ADSCs were measured
at passages 5, 10, and 15 by MTT assay (Fig. 1C). Early and late passage
stem cells showed signiﬁcant diﬀerences at 3 days after seeding. At
7 days after seeding, late passage TMSCs and hMSCs showed only 37%
proliferation ability in the early passage. Late passage ADSCs showed
43% proliferation ability compared to early passage cells at 7 days after
seeding. All stem cells showed passage-dependent proliferation rates.
Early and late passage cells showed signiﬁcant diﬀerences in their
growth rates at the passages evaluated in this study. Therefore, the
Fig. 2. Stem cell migration induced by electrotaxis.
(A) TMSC migration by electrotaxis. (a) TMSCs were manually tracked and cells migration was divided into the right (anode) and left (cathode). (b)Frequency of cell
movement towards the anode and cathode. (c)Cell migration speed was measured at passages 5, 10, and 15 when direct current was applied to the cells. (B) hMSC
migration by electrotaxis. (C) ADSC migration by electrotaxis. * p < .05.
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passage interval selected is suitable for detecting diﬀerences in stem cell
senescence.
To identify gene expression changes during increasing passage, we
detected expression of the senescence markers p16 and p21 and pro-
liferation marker PCNA by western blotting. β-Actin was used as a
loading control. Data for each protein quantiﬁed by the loading control
and band intensity was normalized to the corresponding loading con-
trol. We considered early passage expression as the control level and
calculated the relative intensities in the middle and late passages. The
expression of p16 was found to be related to the passage number
Fig. 2. (continued)
Fig. 3. Schematic illustration of the study.
Early passage cells are presented in white color and late passage cells in blue color. Stem cells migrate randomly under normal conditions in both early and late
passages. However, when stem cells are stimulated by a direct electric current, early passage stem cells migrated primarily towards the anode. Late passage stem cells
showed a decreased tendency to migrate towards the anode. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web
version of this article.)
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(Fig. 1D). p16 expression increased during serial passage. p21 was in-
creased at the middle passage and decreased at the late passage in
TMSCs and ADSCs, indicating that senescence was initiated in the
middle passage. In contrast, in hMSCs, p21 was consistently increased
during the late passage. In all cell types, PCNA decreased with in-
creasing passage numbers. p16 and p21 signal transduction cascades
commonly activate the senescence pathway. Particularly, p16 is ele-
vated during senescence process and act critical in senescence cycle.
However, p21 decreases from its maximum value at the initiation of
senescence (Herranz and Gil, 2018; Stein et al., 1999). Therefore, p21 is
important in the onset of senescence, whereas p16 maintains senes-
cence. PCNA is an important factor in proliferation and is decreased
during senescence.
Stem cells are considered as promising tools for tissue engineering
and cell therapies. However, stem cells have a limited lifespan, limiting
their applications in tissue engineering and cell therapies (Herranz and
Gil, 2018). Increasing the passage number by long-term culture, re-
ferred as late passage stem cells, alters their innate characteristics be-
cause of senescence (Gu et al., 2016). Serially passaging in vitro culture
results in a decreased cell diﬀerentiation potential, including lineage-
dependent eﬀects due to senescence. (Kretlow et al., 2008; Zhou et al.,
2008). As the passage number of bone marrow-derived MSCs is in-
creased, adipogenic diﬀerentiation shows a signiﬁcant diﬀerence be-
tween early and late passage cells. Late passage bone marrow-derived
MSCs have a low ability to diﬀerentiate compared to early passage cells
(Kretlow et al., 2008). Implanting undiﬀerentiated stem cells can cause
side eﬀects such as tumorigenicity. Thus, using early passage cells is
important for improving cell therapy outcomes.
3.2. Migration of stem cells in electrotaxis is passage-related
“Electrotaxis” referes to the direction of cell direction in response to
electric stimulation. Using electrotaxis, cells are stimulated by an
electric current, which is an easy method for controlling cellular posi-
tioning, precisely and rapidly revealing changes compared to other
methods. Cells preferentially moved towards one of the electrodes, as
polarized eﬀects are induced by ion transport or redistribution of
charged cell-surface molecules (Cortese et al., 2014). Our system used
an agar-salt bridge to apply a stable direct current between the power
supply and customized electrotaxis chamber into which the cells were
seeded.
To analyze migration upon direct electric current stimulation of
TMSCs, hMSCs, and ADSCs, the cells were tracked in 5-min intervals for
3 h in the electrotaxis chamber. The migration speed was calculated as
the accumulated migration distance divided by the total migration
observation time. The percentage of cells migrating towards the anode
and cathode was divided based on a center point. Cell movement to the
right side of the center point, was considered as directional movement
towards the anode while cell migration to left side of the center point
was considered as migration towards the cathode.
TMSCs showed passage-dependent speed diﬀerences in the presence
and absence of electric current stimulation. No signiﬁcant diﬀerences in
the migration speed at hMSCs and ADSCs were found in diﬀerent pas-
sages. Therefore, evaluating the migration speed does not explain
passage-related diﬀerences in all cell types (Fig. 2Ac, 2Bc, 2Cc). TMSCs,
hMSCs, and ADSCs moved randomly in the absence of a direct current
at all passages (Fig. 2Aab, 2Bab, 2Cab). However, under stimulation
with a direct current, the cells migrated in a directional manner. In
TMSCs, hMSCs, and ADSCs, the cells moved towards anode when a
direct current was applied. Interestingly, under a direct current, cell
migration towards the anode tended to decrease with serial passaging.
In TMSCs 95% of passage 5 cells moved towards the anode, while 78%
of passage 15 cells moved towards the anode. In hMSCs 96% of passage
5 cells moved towards the anode, while 81% of passage 15 cells moved
towards the anode. In ADSCs, 95% of passage 5 cells moved towards the
anode, while 76% of passage 15 cells moved towards the anode.
The migration orientation did not change with increasing passage
numbers in stem cells. Stem cells moved towards the electrode under
stimulation with an electric current at 1000 μA for 3 h, which did not
aﬀect cell viability (Kim et al., 2017). Additionally, weak electrotaxis
does not cause cell diﬀerentiation (Zhao et al., 2011). Therefore, ap-
plying a direct electric current for 3 h at a power of 1000 μA does not
alter the viability or osteogenic potency of stem cells.
Long-term serial passaging of MSCs causes the cells to become se-
nescent with reduced osteogenic diﬀerentiation potential and decreased
proliferation potential (Zaim et al., 2012; Siddappa et al., 2007). This
may explain why cell lose their migratory directional potency, parti-
cularly in electrotaxis. Cell electrotaxis is passage-dependent, and long-
term culture cells showed a decreased directional frequency. Thus,
diﬀerent migration tendencies may be related to cell innate character-
istics (Zhao et al., 2011).
Identifying cell sources in stem cell therapy is important and better
results are obtained when early passage stem cells are used. Increasing
the passage number by serial subculture in vitro causes cell senescence
and alters cellular characteristics. Migration characteristics are also
inﬂuenced by external and internal stimulation. In this study, we used
electrotaxis to compare early and late passage stem cells. Without a
direct electric current, TMSCs, hMSCs, and ADSCs moved, making it
diﬃcult to analyze passage-dependent movement. However, when stem
cells were under a direct electric current, cells migrated towards the
anode. As the stem cells passage number increased, the percent of mi-
gration towards to anode decreased. In conclusion, our results de-
monstrate that analyzing stem cell migration with electrotaxis is useful
for comparing early passage and late passage stem cells (Fig. 3).
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